Amid a tightened fundraising environment, life sciences companies should double down on basics like focusing on key projects and getting out data, and look at creative ways to raise capital.
Those were some of the take-home messages from venture capitalists and other investors at a panel discussion at the 2023 Life Science Washington Innovation Northwest meeting last week.
